Search by Drug Name or NDC

    NDC 31722-0155-01 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1 Details

    DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

    DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

    Product Information

    NDC 31722-0155
    Product ID 31722-155_eac552ea-6080-4935-a154-39ab177ef350
    Associated GPIs 61109902100305
    GCN Sequence Number 004999
    GCN Sequence Number Description dextroamphetamine/amphetamine TABLET 5 MG ORAL
    HIC3 J5B
    HIC3 Description ADRENERGICS, AROMATIC, NON-CATECHOLAMINE
    GCN 56970
    HICL Sequence Number 013449
    HICL Sequence Number Description DEXTROAMPHETAMINE SULF-SACCHARATE/AMPHETAMINE SULF-ASPARTATE
    Brand/Generic Generic
    Proprietary Name DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1.25; 1.25; 1.25; 1.25
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervo
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA213709
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0155-01 (31722015501)

    NDC Package Code 31722-155-01
    Billing NDC 31722015501
    Package 100 TABLET in 1 BOTTLE (31722-155-01)
    Marketing Start Date 2021-05-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.24282
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DEXTROAMP-AMPHETAMINE 5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis